ExCEEd Orphan distribution d.o.o.

ExCEEd Orphan is a biopharmaceutical services company specializing in orphan drugs for rare diseases across Central and Eastern Europe. The company helps life-science and biotech firms with market access, commercialization, regulatory affairs, and distribution in 17 countries throughout the region. Its team brings more than 100 years of combined experience in the healthcare and pharmaceutical industries. In 2022, Rafa Laboratories acquired a significant stake in ExCEEd Orphan to strengthen its international presence in rare disease markets. The company’s portfolio covers therapeutic areas such as hematology, neurology, immunology, and metabolic disorders.